• International
  • Albania
  • Bosnia and Herzegovina
  • Bulgaria
  • Croatia
  • Czech Republic
  • Estonia
  • Hungary
  • Latvia
  • Lithuania
  • Kosovo
  • North Macedonia
  • Poland
  • Romania
  • Serbia
  • Slovakia
  • Slovenia
  • Switzerland (German)
  • Switzerland (French)
  • Business Development
  • Medien
  • Treffen Sie uns
  • Karriere
  • Kontakt
ewopharma
  • Unsere Produkte
  • Partner & Marken
    • Referenzen
  • Über Ewopharma
    • Vision/Mission
    • Unsere Werte
    • Unsere Strategie
    • Führung
    • Unternehmensverantwortung
    • Gebiet
  • Business Development
  • Medien
  • Treffen Sie uns
  • Karriere
  • Kontakt
  • International
  • Albania
  • Bosnia and Herzegovina
  • Bulgaria
  • Croatia
  • Czech Republic
  • Estonia
  • Hungary
  • Latvia
  • Lithuania
  • Kosovo
  • North Macedonia
  • Poland
  • Romania
  • Serbia
  • Slovakia
  • Slovenia
  • Switzerland (German)
  • Switzerland (French)
 

Medien

Unser Logo

Download Logo

 

KONTAKT

Ewopharma AG
Vordergasse 43
8200 Schaffhausen
Schweiz

Tel.: +41 52 633 09 99
E-Mail: pr@ewopharma.com

PRESSEMITTEILUNGEN

  • Vorherige
  • 1
  • 2
  • 3
  • 4
  • Nächste
[Translate to Switzerland (German):]
27.05.2024

Ewopharma and CStone enter into a Strategic Partnership for Sugemalimab in Central Eastern Europe and Switzerland

Mehr lesen
30.01.2024

Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication

Mehr lesen
31.05.2023

Neomed s.r.o. becomes part of Ewopharma Group

Mehr lesen
29.04.2022

Calmino and Ewopharma join up to treat Irritable Bowel Syndrome (IBS)

Mehr lesen
17.05.2021

Neobiomics AB and Ewopharma AG announce an exclusive collaboration for distribution of ProPrems® in Switzerland

Mehr lesen
  • Vorherige
  • 1
  • 2
  • 3
  • 4
  • Nächste

HAUPTSITZ
Ewopharma AG
Vordergasse 43
8200 Schaffhausen
Switzerland

 

KONTAKT
Tel. +41 52 633 09 99
E-Mail: info@remove-this.ewopharma.com

 

  • Datenschutzerklärung
  • Cookie Policy
  • Impressum
  • VPOIS

Copyright © Ewopharma AG